Haemonetics (HAE) Gains from Investment Securities (2013 - 2022)
Haemonetics (HAE) posted Gains from Investment Securities of -$504000.0 for Q3 2022, down 366.67% on a QoQ basis from $189000.0 in Q2 2022, and down 105.16% year-over-year from $9.8 million in Q3 2021.
Analysis
Haemonetics (HAE) Gains from Investment Securities (2013 - 2022) Analysis & Trends
Haemonetics has reported Gains from Investment Securities for 5 years, with the latest figure at -$504000.0 in Q3 2022.
- On a quarterly basis, Gains from Investment Securities fell 105.16% year-over-year to -$504000.0 in Q3 2022; TTM through Apr 2023 was -$504000.0, a 104.82% decrease from a year earlier, with the FY2023 full-year figure at -$504000.0, down 104.82% from the prior year.
- Gains from Investment Securities was -$504000.0 for Q3 2022 at Haemonetics, down from $189000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $9.8 million in Q3 2021, with the low at -$504000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Haemonetics | 4.60 Bn | 4.37 Bn | 202.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 2, 2022 | -504,000.00 |
| Apr 2, 2022 | 189,000.00 |
| Jan 1, 2022 | 927,000.00 |
| Oct 2, 2021 | -429,000.00 |
| Jul 3, 2021 | 9.77 Mn |
| Dec 26, 2015 | -4.90 Mn |
| Sep 26, 2015 | 88,000.00 |
| Jun 27, 2015 | 83,000.00 |
| Mar 28, 2015 | -3.62 Mn |
| Dec 27, 2014 | 246,000.00 |
| Sep 27, 2014 | 235,000.00 |
| Jun 28, 2014 | 224,000.00 |
| Mar 29, 2014 | -1.14 Mn |
| Dec 28, 2013 | 872,000.00 |
| Sep 28, 2013 | 189,000.00 |
| Jun 29, 2013 | 121,000.00 |